News & Events
KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
27 / 02 / 2012
Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
Dr. Fuchs TV interview
16 / 02 / 2012
VIDEO - Dr. Fuchs' interview on Philadelphia's ABC is an excellent piece that highlights the exciting potential of amitifadine.
Sunshine Heart Announces NASDAQ Listing
15 / 02 / 2012
Sunshine Heart, Inc. today announced that its application to list the Companyâ??s common shares on the NASDAQ Capital Market (NASDAQ) has been approved by NASDAQ and its related Registration Statement on Form 10 filed with the U.S. Securities Exchange Commission (SEC) has been declared effective.
Celladon Corporation Completes $43 Million Financing
15 / 02 / 2012
Celladon Corporation Completes $43 Million Financing to advance its lead investigational product candidate MYDICAR® for the treatment of heart failure.
Spinifex chosen for 4th BioSpectrum Asia- Pacific Emerging Company of the Year Award 2012
14 / 02 / 2012
The company was chosen for its innovative work on EMA401, a potential first-in-class oral treatment for neuropathic pain and related symptoms without central nervous system side effects
Julie Cherrington Appointed Chair of Xenomeâ??s Board of Directors to Lead in Critical Phase
17 / 01 / 2012
UPTAKE MEDICAL ANNOUNCES TGA APPROVAL OF INTERVAPOR FOR PATIENTS WITH SEVERE EMPHYSEMA
22 / 12 / 2011
First Patient Treated in IDE Trial of New Post-Mastectomy Expansion Device
06 / 12 / 2011
The XPAND trial will evaluate AeroFormâ?¢ as a possible alternative to standard tissue expansion in breast reconstruction process